Showing results (521-530 of 684) with videos related to

Sort By:
Pageof 69
The Annals of Thoracic Surgery|May 28, 2023
Role of Adjuvant Chemotherapy in Early-Stage Combined Small Cell Lung CancerArian Mansur, Alexandra L Potter, Alexandra T Nees, et al.
The Journal of Surgical Research|March 14, 2023
Wedge Resection Versus Segmentectomy for Older Patients With Stage IA Non-Small-Cell Lung CancerCamille Mathey-Andrews, Alexandra L Potter, Shivaek Venkateswaran, et al.
Biochemical and Biophysical Research Communications|August 15, 1995
Calcium dependent K-channels in guinea pig and human urinary bladderS Trivedi, L Potter-Lee, J H Li, et al.
Science Advances|April 24, 2021
Multiple substrate recognition by yeast diadenosine and diphosphoinositol polyphosphate phosphohydrolase through phosphate clampingMaría Ángeles Márquez-Moñino, Raquel Ortega-García, Megan L Shipton, et al.
The Annals of Thoracic Surgery|January 26, 2025
Assessing Lung Cancer Screening Eligibility of Patients With Lung Cancer in the Boston Lung Cancer Study: An Analysis of 7186 Lung Cancer CasesAlexandra L Potter, Quiana Guo, Deepti Srinivasan, et al.
Chembiochem : a European Journal of Chemical Biology|June 7, 2006
scyllo-inositol pentakisphosphate as an analogue of myo-inositol 1,3,4,5,6-pentakisphosphate: chemical synthesis, physicochemistry and biological applicationsAndrew M Riley, Melanie Trusselle, Paul Kuad, et al.
Chest|July 1, 2025
Segmentectomy vs Lobectomy for Patients With 2- to 3-cm Non-Small Cell Lung CancerCamille A Mathey-Andrews, Alexandra L Potter, Deepti Srinivasan, et al.
Clinical Nuclear Medicine|April 17, 2024
High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and ParagangliomaRuaa Al-Ward, Vania Balderrama Brondani, Sahar Sawani, et al.
Journal of Medicinal Chemistry|April 15, 2005
Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitorsHarshani R Lawrence, Nigel Vicker, Gillian M Allan, et al.
Journal of Medicinal Chemistry|September 15, 2006
Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligandsTetsuya Mochizuki, Yoshihiko Kondo, Hiroshi Abe, et al.
Pageof 69